Furthermore, mice immunised with PRMT5 showed marked tissue fibrosis coupled with immune cell infiltration within both dermal and pulmonary tissues, as well as serological antibody response, mirroring the pathognomonic changes typically associated with human SSc. Here, PRMT5 is linked to systemic sclerosis.